Cable Car Capital’s Valion Bio VBIO Stock Holding History

Cable Car Capital’s Portfolio VBIO Stock Details VBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,471	Closed	-$109K	–	72
2024 Q2	$109K	Buy	+16,471	New	+$207K	0.12%	43

Other funds holding VBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cable Car Capital's VBIO Position: Q3 2024 in Review

Cable Car Capital sold out of Valion Bio (VBIO) in Q3 2024, closing a stake of 16,471 shares — an estimated $109K sold.

Cable Car Capital first reported a position in VBIO in Q2 2024 and held it in 1 quarter. The position peaked at $109K in Q2 2024. 10 funds tracked by Wall St. Rank hold VBIO as of Q3 2024.

Cable Car Capital reported no remaining Valion Bio position as of Q3 2024 after selling out during the quarter.
Cable Car Capital sold 16,471 Valion Bio shares in Q3 2024, an estimated $109K.
Cable Car Capital first reported a position in Valion Bio in Q2 2024 and held it in 1 quarter.
Cable Car Capital's Valion Bio position peaked at $109K in Q2 2024.
10 funds tracked by Wall St. Rank held Valion Bio as of Q3 2024.

Based on Cable Car Capital's 13F filing for Q3 2024, filed 14 Nov 2024.